Brainsway (TLV:BWAY), (NASDAQ:BWAY) specializes in the development and marketing of advanced neurostimulation treatments for mental health disorders. The company's main focus is on its patented Deep Transcranial Magnetic Stimulation (Deep TMS) technology, a non-invasive treatment designed to target areas of the brain associated with mood and behavior disorders. Brainsway aims to improve the well-being of patients suffering from a variety of mental health conditions, including major depressive disorder, obsessive-compulsive disorder, and smoking addiction, among others. Through continuous research and development, Brainsway strives to expand the applications of Deep TMS technology to address a wider range of neurological and psychiatric disorders, working towards the objective of offering effective, accessible, and safe treatment alternatives for patients worldwide.